Graham Capital Management’s GoodRx Holdings GDRX Stock Holding History

Graham Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-224,073	Closed	-$607K	–	1297
2025 Q4	$607K	Buy	+224,073	New	+$736K	0.01%	556
2025 Q3	–	Sell	-54,145	Closed	-$270K	–	1392
2025 Q2	$270K	Buy	54,145 +21,069	+64%	+$91.5K	﹤0.01%	1031
2025 Q1	$146K	Sell	33,076 -59,672	-64%	-$280K	﹤0.01%	1172
2024 Q4	$431K	Buy	+92,748	New	+$510K	0.01%	793
2024 Q2	–	Sell	-40,432	Closed	-$287K	–	1149
2024 Q1	$287K	Sell	40,432 -92,592	-70%	-$612K	0.01%	801
2023 Q4	$891K	Buy	+133,024	New	+$749K	0.02%	414
2023 Q1	–	Sell	-158,396	Closed	-$738K	–	1150
2022 Q4	$738K	Buy	+158,396	New	+$780K	0.02%	643

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Graham Capital Management's GDRX Position: Q1 2026 in Review

Graham Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 224,073 shares — an estimated $607K sold.

Graham Capital Management first reported a position in GDRX in Q4 2022 and held it in 7 quarters. The position peaked at $891K in Q4 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

Graham Capital Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 224,073 GoodRx Holdings shares in Q1 2026, an estimated $607K.
Graham Capital Management first reported a position in GoodRx Holdings in Q4 2022 and held it in 7 quarters.
Graham Capital Management's GoodRx Holdings position peaked at $891K in Q4 2023.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.